human fatty liver disease: old questions new insights
nonalcoholic fatty liver disease nafld burgeoning health problem affects one-third adults increasing number children developed countries disease begins aberrant accumulation triglyceride liver individuals elicits inflammatory response can progress cirrhosis liver cancer although nafld strongly associated obesity insulin resistance pathogenesis remains poorly understood therapeutic options limited discuss recent mechanistic insights nafld focusing primarily emerged human genetic metabolic studies
